
Prellis Biologics is building human tissues for drug development, and ultimately, developing human organs for transplantation. Bioprinting vascularized human tissue and organs will revolutionize…

Prellis Biologics is building human tissues for drug development, and ultimately, developing human organs for transplantation. Bioprinting vascularized human tissue and organs will revolutionize…
What they do: 3D-printed lymph node organoids and an AI-enabled EXIS platform for antibody discovery and human tissue development
Founded: 2016
Headquarters: Berkeley / San Francisco Bay Area, California
Recent funding: Series C announced Mar 10, 2025
Notable investors: Khosla Ventures, Celesta Capital, Avidity Partners, SOSV/IndieBio, True Ventures
Antibody discovery, therapeutic development, and translational human tissue engineering (bioprinted tissues/organs).
2016
Biotechnology Research
14500000
Reported $14.5M Series B announced December 15, 2021
Most-recent funding event listed as Series C announced March 10, 2025
“Backed by multiple institutional investors including Khosla Ventures, Celesta Capital, Avidity Partners, SOSV/IndieBio, True Ventures and others”
| Company |
|---|
About Prellis Biologics At Prellis we integrate human biology with machine learning. We aim to revolutionized drug discovery by harnessing the power of human immune system with tightly, integrated machine learning to develop next-generation antibody therapeutics with unparalleled speed, precision and safety. We are committed to empowering our pharmaceutical partners with access to the most promising fully human body candidate rapidly identified from the human immune repertoire, enabling them to bring life-changing treatments to patients faster than ever before. Prellis Biologics is a pre-IPO biotech located in Berkeley CA with a team-oriented, inclusive, and family-friendly culture. Our growing pipeline target high unmet patient needs across therapeutics including metabolic, inflammation, and oncology disease. Prellis has raised funding from top investors, including Celesta, Khosla Ventures, SOSV, & Avidity Partners.
About The Role You?ll architect and hands-on build the end-to-end scientific data platform that powers antibody discovery and characterization. This includes a well-structured PostgreSQL backbone on AWS, reliable ETL from lab systems (Benchling, PipeBio, instruments), and a scientist-friendly app (Shiny or Python) with built-in analytics and visualizations. You?ll design for FAIR data (Findable, Accessible, Interoperable, Reusable) and publish AI/ML-ready datasets with clear lineage and versioning.
Key Responsibilities Platform architecture & data modeling (Postgres on AWS)
FAIR by design & governance
Ingestion & transformation (ETL/ELT)
Analytics & visualization (data + display layers)
Application layer
AI/ML interface
Technical leadership
Immediate Projects
Minimum Qualifications
Nice to have
What You Can Expect Of Us As we work to develop treatments that take care of others, we also work to care for your professional and personal growth and well-being. From our competitive benefits to our collaborative culture, we?ll support your journey every step of the way.
The expected annual salary range for this role in the U.S. is posted. Actual salary will vary based on several factors including but not limited to, relevant skills, experience, and qualifications.
Benefits In addition to the base salary, Prellis offers compelling benefits based on eligibility, comprising of health and welfare plans for staff and eligible dependents, financial plans with opportunities to save towards retirement or other goals, work/life balance, and career development opportunities that may include:
Application deadline Prellis does not have an application deadline for this position; we will continue accepting applications until we receive a sufficient number or select a candidate for the position.
Prellis Bio is an equal opportunity employer. All applicants will be considered for employment without attention to race, color, religion, sex, sexual orientation, gender identity, national origin, veteran or disability status.
We believe diversity, equity, and inclusion need to be at the foundation of our culture. We work hard to bring together diverse teams?grounded in a wide range of expertise and life experiences?and work even harder to ensure those teams thrive in inclusive, growth-oriented environments supported by equitable company and team practices. All candidates can expect equitable treatment, respect, and fairness throughout the interview process.
Your next opportunity is in here somewhere. Sign up to explore 70,000+ startups and their open roles. No spam. No gamification. Just jobs.
70,000+
Startups
81,000+
Open Roles
4,600+
New This Week